A randomized, controlled, multicenter phase III clinical trial of Huo Xiang Zheng Qi oral liquid for the prevention and control of nausea and vomiting caused by multiday cisplatin-based regimen.

Medicine (Baltimore) · 2025 · PMC12746988 · PMID 41466018

Europe PMC DOI

hedged sentences

0.4970

closest p · 9.9× alpha

0.4970

boldest claim

The sentences

did not reach statistical significanceP = .497not close (p > 0.1)

Life function According to the FLIE scale score on day 7 of chemotherapy, the mean score of patients in the group HX was 101.49 ± 28.36, which was higher than that of patients in the group C (98.26 ± 27.52), but the difference did not reach statistical significance ( P = .497).

also in 111,027 other papers

showed a trendno p-value reported

Group HX also showed a trend to better functional living index-emesis score, but only achieved the significance during the period beyond the risk phase.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.